Is ROL a Buy? What to Consider in 2026
Last updated July 2026
Short answer
The bull case for Rollins (ROL) rests on Recurring, non-discretionary demand: Pest and termite control is largely a need-to-do service, not a discretionary purchase, so a large portion of Rollins revenue recurs on contracts and repeat routes. Revenue (TTM) is ~$3.9B. If you believe that thesis holds, the real questions become position sizing and overlap, not timing. The main risk to that view: Valuation is the central risk: ROL trades at a premium earnings multiple (well above the broader market) that already assumes years of consistent growth, so any slowdown could compress the multiple sharply. Whether ROL is a buy comes down to whether you believe the thesis. This is informational, not a recommendation, and Walnut is not an investment adviser.
Rollins, Inc. is a US-based consumer and commercial services company that provides pest and termite control through a family of brands led by Orkin, alongside HomeTeam Pest Defense, Clark Pest Control, Fox Pest Control, Critter Control, Trutech, and many others across the US, Canada, Australia, and other markets. The business is built on recurring, contract-based service routes: residential pest control, commercial pest control, and termite and ancillary services, with a large share of revenue tied to repeat visits that give it visibility and pricing power. Rollins grows both organically (price and new customers) and through a steady stream of small tuck-in acquisitions of local operators in a highly fragmented industry. The investment picture is one of a defensive compounder. Demand for pest control is largely non-discretionary and recession-resistant, and Rollins pairs mid-single-digit organic growth with acquisition-driven revenue and consistent free cash flow that funds a growing dividend and buybacks. The debate centers on valuation and margins: the stock carries a premium multiple that reflects its quality and consistency, and recent quarters have shown some operating-margin compression from acquisition mix and cost inflation even as revenue growth stayed strong.
What's the case for buying ROL?
1. Recurring, non-discretionary demand
Pest and termite control is largely a need-to-do service, not a discretionary purchase, so a large portion of Rollins revenue recurs on contracts and repeat routes. That gives the business unusual visibility and resilience through economic cycles. It is the foundation of the company's steady mid-single-digit organic growth.
2. Acquisition roll-up in a fragmented market
The pest-control industry is highly fragmented across thousands of regional operators, and Rollins runs a continuous program of small tuck-in acquisitions to add density and customers. In early 2026 it closed several deals and announced the roughly $90 million Romex Pest Control acquisition. This roll-up strategy has added several points of growth on top of the organic base for years.
3. Pricing power and route density
Scale and high route density let Rollins service more customers per technician mile, supporting margins and letting it pass through inflation via annual price increases. Residential, commercial, and termite lines all grew in the high single to low double digits in recent quarters. The combination of pricing plus volume drives durable top-line compounding.
4. Cash generation funding dividend and buybacks
Rollins is asset-light and strongly cash-generative, converting a high share of earnings into free cash flow. That funds a regularly raised dividend, share repurchases, and the acquisition pipeline without heavy leverage. The capital-return profile is a core part of the long-term total-return story.
What are the risks to ROL?
Valuation is the central risk: ROL trades at a premium earnings multiple (well above the broader market) that already assumes years of consistent growth, so any slowdown could compress the multiple sharply. Operating margins have shown some compression recently from acquisition mix and cost inflation, and a heavy reliance on M&A carries integration and overpayment risk. Organic growth can soften with a weak housing market or unusually mild weather that reduces pest activity. Competition from Rentokil (which now owns Terminix), Ecolab, Aptive, and well-funded private-equity roll-ups could pressure pricing and deal prices. Labor availability and wage inflation for technicians are ongoing cost pressures.
How is ROL valued? (as of July 2026)
Snapshot for ROL as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
- Revenue (TTM): ~$3.9B
- FY2025 revenue: ~$3.8B (+11%)
- Q1 2026 revenue: ~$906M (+10.2%)
- Market cap: ~$20B
- Trailing P/E: ~38x
- Dividend yield: ~1.5%
Rollins grew FY2025 revenue about 11% to roughly $3.8 billion, with organic growth near 7% and the rest from acquisitions, and carried that momentum into Q1 2026 with about 10% growth. Profitability remains high but operating margin dipped year over year (to around 16% in Q1 2026) on acquisition mix and cost inflation. The stock trades at a premium valuation, with a trailing P/E in the high 30s and a forward P/E in the low 30s, reflecting its recurring-revenue quality.
How do you decide if ROL is a buy?
Rather than asking whether ROL is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold ROL indirectly through an index or sector ETF before adding more.
For the full picture, see the ROL stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about ROL against your real portfolio and see your actual exposure before deciding.
The bottom line on ROL
The bottom line: Rollins's story right now is Recurring, non-discretionary demand, with revenue (ttm) at ~$3.9B. If you believe that narrative continues, the call is about sizing ROL sensibly and checking overlap with what you own; if you doubt it (the risk: valuation is the central risk: ROL trades at a premium earnings multiple (well above the broader market) that already assumes years of consistent growth, so any slowdown could compress the multiple sharply.), it is not for you. Decide from the thesis, not the ticker. Walnut is not an investment adviser.
Build a basket around ROL with Walnut
Use Rollins as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
Is ROL a good stock to buy right now?
+
The case for Rollins right now is Recurring, non-discretionary demand, with revenue (ttm) at ~$3.9B. If you believe that thesis holds, ROL is a way to own it and the real questions are sizing and overlap, not timing; the main risk to that view is valuation is the central risk: ROL trades at a premium earnings multiple (well above the broader market) that already assumes years of consistent growth, so any slowdown could compress the multiple sharply. So it comes down to whether you believe the thesis. Walnut is not an investment adviser and this is not a recommendation.
What does Rollins do?
+
Rollins, Inc.
What are the main risks of ROL?
+
Valuation is the central risk: ROL trades at a premium earnings multiple (well above the broader market) that already assumes years of consistent growth, so any slowdown could compress the multiple sharply. Operating margins have shown some compression recently from acquisition mix and cost inflation, and a heavy reliance on M&A carries integration and overpayment risk. Organic growth can soften with a weak housing market or unusually mild weather that reduces pest activity. Competition from Rentokil (which now owns Terminix), Ecolab, Aptive, and well-funded private-equity roll-ups could pressure pricing and deal prices. Labor availability and wage inflation for technicians are ongoing cost pressures.
What does Rollins (ROL) do?
+
Rollins provides pest and termite control services to homes and businesses through brands led by Orkin, plus HomeTeam Pest Defense, Clark Pest Control, Fox Pest Control, and many others. Its revenue is largely recurring, tied to contracts and repeat service routes across the US and several international markets.
Is ROL a good long-term holding?
+
Rollins has the traits investors often prize in a long-term compounder: recurring, non-discretionary revenue, steady organic growth, consistent free cash flow, and a rising dividend. The main tradeoff is a premium valuation that already reflects that quality. Whether it fits a given portfolio depends on your goals and risk tolerance, not on any recommendation here.
Why is ROL's P/E ratio so high?
+
Rollins trades at a trailing P/E in the high 30s because the market pays up for its recurring revenue, recession resistance, and long record of consistent growth. A premium multiple means a lot of good news is already priced in, so future returns depend partly on whether growth keeps meeting those expectations.
Does Rollins pay a dividend?
+
Yes. Rollins pays a quarterly dividend that it has raised regularly over many years, with a yield around 1.5%. The dividend is modest but growing, funded by the company's strong free cash flow alongside share buybacks and acquisitions.
Walnut is informational and is not an investment adviser. This page is educational and not a recommendation to buy or sell ROL; figures are approximate and dated, and your own situation, time horizon, and risk tolerance should drive any decision. Verify current data before investing.